KEYVANTAGE WEALTH, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2050555 BETHLEHEM, PA

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$688,932

-$123,037 QoQ

Shares Held

5,453

-6.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.19%

of 13F equity value

Holder Rank

#1,237

of 2,266 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

KEYVANTAGE WEALTH, LLC holds $3,559,634 across 5 Drug Manufacturers - General names. GILD ranks #3 (19.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,167	$1,058,292
2	LLY	ELI LILLY & Co	594	$712,461
3	GILD	Gilead Sciences, Inc. This page	5,453	$688,932
4	MRK	Merck & Co., Inc.	4,857	$624,124
5	AMGN	Amgen Inc	1,314	$475,825

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$688,932	5,453	-6.4%	Shares	Sole	2026-08-11
2026-03-31	$811,969	5,826	+10.5%	Shares	Sole	2026-05-05
2025-12-31	$647,085	5,272	-0.9%	Shares	Sole	2026-02-10
2025-09-30	$590,631	5,321	-4.3%	Shares	Sole	2025-11-07
2025-06-30	$616,548	5,561	-1.3%	Shares	Sole	2025-08-08
2025-03-31	$631,513	5,636	-13.6%	Shares	Sole	2025-05-07
2024-12-31	$602,252	6,520	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.